Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

17.01.17	FDA Delays Decision On Lilly's Rheumatoid Arthritis Drug Candidate (RTTNews)
13.01.17	U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment (PR Newswire)
13.01.17	Teva Loses Alimta Appeal Against Eli Lilly (RTTNews)
12.01.17	U.S. Court of Appeals Rules In Lilly's Favor On Alimta Vitamin Regimen Patent (PR Newswire)
11.01.17	Lilly, Merck Expand Immuno-Oncology Collaboration (RTTNews)
11.01.17	Lilly and Merck Expand Immuno-Oncology Collaboration (PR Newswire)
05.01.17	Lilly Confirms Date and Conference Call for Fourth-Quarter 2016 Financial Results Announcement (PR Newswire)
05.01.17	Lilly Announces Changes In Organization, Leadership Structure - Quick Facts (RTTNews)
05.01.17	Lilly to Adjust Organization and Leadership Structure to Better Align with Growth Opportunities (PR Newswire)
04.01.17	U.S. FDA approves supplemental New Drug Applications to include landmark data in product labels for Synjardy® (empagliflozin/metformin hydrochloride), Synjardy® XR (empagliflozin/metformin... (PR Newswire)
03.01.17	Elanco Animal Health Completes Acquisition of Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio (PR Newswire)
29.12.16	Biotech Stocks Facing FDA Decision In January (RTTNews)
20.12.16	Drug Makers Stocks under Scanner -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline (PR Newswire)
19.12.16	Pricewatch Alert: Adobe Systems, Gulfport Energy, Eli Lilly, Coca-Cola, and Visa and more offer option-trading opportunities that offer returns of more than 20% (PR Newswire)
16.12.16	CHMP Recommends Approval Of Lilly's Baricitinib For Rheumatoid Arthritis (RTTNews)
16.12.16	CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis (RA) (PR Newswire)
15.12.16	Lilly, Boehringer: Basaglar, A Long-Acting Basal Insulin, Now Available In US (RTTNews)
15.12.16	BASAGLAR® (insulin glargine injection 100 units/mL), A Long-Acting Basal Insulin, Is Now Available in U.S. (PR Newswire)
15.12.16	Lilly Cuts FY16 EPS View, Backs Adj. EPS Forecast; Sees Growth In FY17 (RTTNews)
15.12.16	Lilly Provides 2017 Financial Guidance and 2016 Update, Reaffirms Financial Expectations Through the Remainder of the Decade (PR Newswire)
13.12.16	Lilly Announces Program To Provide Insulin At Discounted Prices Starting Jan. 1 (RTTNews)
13.12.16	Lilly Announces Program to Provide Insulin at Discounted Prices (PR Newswire)
13.12.16	Lilly : FDA Approves Synjardy XR Tablets For Adults With Type 2 Diabetes (RTTNews)
13.12.16	Lilly Announces Dividend Increase (PR Newswire)
12.12.16	U.S. FDA approves Synjardy® XR (empagliflozin/metformin hydrochloride extended-release) tablets for adults with type 2 diabetes (PR Newswire)
09.12.16	Lilly And AstraZeneca In Deal To Co-develop MEDI1814 (RTTNews)
09.12.16	Lilly and AstraZeneca to Develop Second Potentially Disease-Modifying Treatment for Alzheimer's Disease (PR Newswire)
09.12.16	Lilly Reports Detailed Results Of Solanezumab Phase 3 EXPEDITION3 Study (RTTNews)
09.12.16	Lilly Announces Detailed Results of Solanezumab Phase 3 EXPEDITION3 Study at the Clinical Trials on Alzheimer's Disease (CTAD) 2016 Meeting (PR Newswire)
09.12.16	Lilly Announces Detailed Results of Solanezumab Phase 3 EXPEDITION3 Study at the Clinical Trials on Alzheimer's Disease (CTAD) 2016 Meeting (PR Newswire)
08.12.16	Lilly Presents NeoMONARCH Phase2 Data On Abemaciclib In EarlyStage Breast Cancer (RTTNews)
08.12.16	Lilly Presents neoMONARCH Phase 2 Data on Abemaciclib in Early-Stage Breast Cancer (PR Newswire)
05.12.16	FDA Approves Jardiance Tablets To Reduce Cardiovascular Death Risk In Diabetes (RTTNews)
05.12.16	FDA Approves Jardiance Tablets To Reduce Cardiovascular Death Risk In Diabetes (RTTNews)
05.12.16	U.S. FDA approves Jardiance® (empagliflozin) tablets to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease (PR Newswire)
02.12.16	Lilly Confirms Date and Conference Call for 2017 Financial Guidance Announcement (PR Newswire)
30.11.16	Lilly Introduces Scholars Programs for Florida A&M University's and Howard University's Business Students (PR Newswire)
25.11.16	JUNO Implodes As ROCKET Is Put On Hold Again, LLY's Expedition Fails (RTTNews)
23.11.16	Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical Trial (PR Newswire)
23.11.16	Lilly Sees Charge In Q4 As Solanezumab Trial Fails To Meet Primary Endpoint (RTTNews)
23.11.16	Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical Trial (PR Newswire)
22.11.16	Survey Reveals Most People Don't Know Heart Disease Is the No. 1 Killer of People with Type 2 Diabetes (PR Newswire)
14.11.16	Lilly Says New Analyses Of Phase 3 Trials Show Improvements In RA Symptom (RTTNews)
25.10.16	Lilly Q3 Results Miss Estimates; Cuts FY16 EPS View, Backs Adj. EPS Forecast (RTTNews)
25.10.16	Eli Lilly And Co. Q3 Profit Declines 2% (RTTNews)
20.10.16	CERU Gains Big On Nanoparticle Deal, LLY Gets FDA Nod, BABY Makes Big Strides (RTTNews)
19.10.16	Eli Lilly Announces FDA Approval For LARTRUVO - Quick Facts (RTTNews)
05.10.16	Eli Lilly Unit To Buy BIVI's U.S. Feline, Canine And Rabies Vaccines Portfo (RTTNews)
05.10.16	Elanco Animal Health Enters Agreement to Acquire Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio (EN, Eli Lilly)
16.09.16	Eli Lilly: CHMP Issues Positive Opinion On Conditional Approval For Olaratumab (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

22:37		TELL me! - der Schweizer Trading Podcast: Microsoft unter Kartellverdacht - Novartis auf einem guten Weg - bei Brenntag könnte das zyklische Tief 2025 kommen
17:58		Optimismus in Europa: Euro STOXX 50 zum Ende des Donnerstagshandels in der Gewinnzone
17:58		Freundlicher Handel in Frankfurt: LUS-DAX verbucht schlussendlich Gewinne
17:58		DAX aktuell: DAX zum Handelsende mit Zuschlägen
15:58		Börse Europa: STOXX 50-Börsianer greifen zu
12:26		Gewinne in Europa: STOXX 50 am Mittag mit Kursplus
09:28		Börse Frankfurt in Grün: DAX beginnt Handel im Plus
09:28		Freundlicher Handel in Europa: Euro STOXX 50 zum Start fester

22:37

TELL me! - der Schweizer Trading Podcast: Microsoft unter Kartellverdacht - Novartis auf einem guten Weg - bei Brenntag könnte das zyklische Tief 2025 kommen

17:58

Optimismus in Europa: Euro STOXX 50 zum Ende des Donnerstagshandels in der Gewinnzone

17:58

Freundlicher Handel in Frankfurt: LUS-DAX verbucht schlussendlich Gewinne

17:58

DAX aktuell: DAX zum Handelsende mit Zuschlägen

15:58

Börse Europa: STOXX 50-Börsianer greifen zu

12:26

Gewinne in Europa: STOXX 50 am Mittag mit Kursplus